To include your compound in the COVID-19 Resource Center, submit it here.

Aventis pharmaceuticals, agbio/veterinary/environmental news

AVE said it plans to divest

Read the full 64 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE